Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Rhesus blood group D antigen (RhD antigen) is a protein found on the surface of red blood cells. It is the most clinically significant antigen in the Rh blood group system. The presence or absence of this antigen determines an individual's Rh status (positive or negative). It plays a role in maintaining the structural integrity of red blood cells and may be involved in ammonium transport. Its primary clinical importance lies in its ability to induce alloimmunization, leading to hemolytic disease of the fetus and newborn (HDFN) and transfusion reactions.
Prevention of RhD alloimmunization
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rhesus blood group D antigen (RhD).